NOVAVAX INC - COM (NVAX)

CUSIP: 670002104

Q2 2017 13F Holders as of 30 Jun 2017

Type / Class
Equity / COM
Total 13F shares
122,809,790
Share change
-13,860,842
Total reported value
$141,236,216
Put/Call ratio
141%
Price per share
$1.15
Number of holders
118
Value change
-$16,159,369
Number of buys
49
Number of sells
50

Quarterly Holders Quick Answers

What is CUSIP 670002104?
CUSIP 670002104 identifies NVAX - NOVAVAX INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NOVAVAX INC - COM (NVAX) as of Q2 2017

As of 30 Jun 2017, NOVAVAX INC - COM (NVAX) was held by 118 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 122,809,790 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, FMR LLC, BB BIOTECH AG, D. E. Shaw & Co., Inc., STATE STREET CORP, JPMORGAN CHASE & CO, FRANKLIN RESOURCES INC, NORTHERN TRUST CORP, and MORGAN STANLEY. This page lists 118 institutional shareholders reporting positions in this security for the Q2 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.